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ABSTRACT: Determination of the kinetics of water-soluble degradation products inside
poly(lactide-co-glycolide) (PLGA) delivery systems during polymer degradation is
important to evaluate the polymer microclimate conditions, particularly microclimate
pH changes for optimization of encapsulated drug stability. A pre-derivatization high-
performance liquid chromatography (HPLC) method was developed for separation and
quantification of water-soluble acid impurities and degradation products in PLGA. Thin
PLGA films (200 mm) were incubated in PBS/0.02% Tween 80, pH 7.4, for 6 weeks.
Water-solublemonomers and oligomers were obtained from polymer films after repeated
CHCl3/H2O extraction and then derivatized into bromophenacyl esters. With the
common chromophore, the esterswere separated and quantified byHPLCwith increased
ultraviolet (UV) sensitivity at 254 nm. The total amount of water-soluble acids in the
extract was validated by potentiometric titration with tetrabutyl ammonium hydroxide.
During the first 3weeks of incubation of PLGA 50:50 (inherent viscosity¼ 0.63 dL/g), the
principal water-soluble acids in the polymer were glycolic, lactic, and lactoyllactic acids,
and an unknown oligomer. After 4 weeks of incubation, a large fraction of higher
molecular weight oligomers was observed. Pre-derivatization HPLC can be used to
accurately measure water-soluble acid distribution, and may be invaluable to examine
the degradation behavior of PLGAs, including the underlying mechanism of polymer
microclimate pH development.  2004 Wiley-Liss, Inc. and the American Pharmacists
Association J Pharm Sci 93:322–331, 2004
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INTRODUCTION
Copolymers of lactic and glycolic acids (PLGAs)
are one of only a few biodegradable polymers used
in pharmaceutical products or medical devices
approved by the United States Food and Drug
Administration (US FDA).1 Initiated in 1960s as
resorbable suture/fiber materials,2 these biode-
gradable and biocompatible polyesters have been
widely investigated as controlled drug delivery
systems for the past few decades, resulting in
several marketed injectable depots,3–5 and have
an excellent safety record.6 Recently, PLGAs have
been the focus of extensive research for long-term
release of therapeutic proteins, and a once-a-
month injectable controlled-release system for
encapsulating human growth hormone is one of
the first products approved by the US FDA among
all the new minimally invasive protein delivery
system options.1
PLGAs are most often synthesized by catalytic
ring opening polymerization with lactide and
glycolide (i.e., the cyclic dimers of lactic and
glycolic acids) as starting materials.7 The ester
backbone undergoes hydrolysis in aqueous envir-
onments, such as body fluids, and the polymer
eventually degrades to lactic and glycolic acid
monomers, which are subsequently eliminated in
vivo as CO2 and H2O via the Krebs cycle.
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addition, varying levels of water-soluble acid
impurities are well known to exist in PLGAs,
which can influence their solid-state stability,
drug encapsulation efficiency, and drug release
behavior.9,10 In general it has been observed
that the hydrolytic degradation of the polymer
depends on several factors, such as polymer com-
position, solid-state morphology, polymer molec-
ular weight, crystallinity, and glass transition
temperature.11–14 The process of polymer degra-
dationhasbeen largely investigatedbymonitoring
the time-dependent changes of polymer molecular
weight, physicomechanical properties, mass loss,
total carboxyl content, andmorphology by employ-
ing the techniques, such as gravimetry, X-ray
diffraction, differential scanning calorimetry,
scanning electronmicroscopy, size-exclusion chro-
matography, and end group assays.10,15–18 Such
investigations, however, have provided little in-
formation about the kinetics of water-soluble
acid distribution inside PLGAs during polymer
degradation.
It is important to gain detailed knowledge of the
existence of the polymer degradation products,
especially water-soluble species, inside polymer
devices. PLGA-based drug delivery systems are
exposed to physiologic conditions for extended
periods, and the resulting polymer microclimate
can play a critical role for encapsulated drug
stability. Recently, it has been demonstrated that
protein stability in PLGAs often has been compro-
mised due to the ubiquitous acidic microclimate
pH (i.e., mpH) caused by the water-soluble acids
in protein regions of the PLGA matrix.1,19–22
Therefore, exact quantification of the type,
amount, and kinetics of water-soluble degradation
products to provide valuable information on mpH
changes is of interest. Such quantification may
also help to elucidate the mechanisms for incom-
plete release of various drugs, whichmay be due to
the possibility of interactions between certain
polymer hydrolytic by-products and those drugs.23
Moreover, acid-quantification may lead to better
understanding of polymer degradation kinetics
and mechanisms.18 Finally, the diffusion of these
water-soluble species out of polymer, depending on
their type and rate, can likely affect the function of
living tissues.24,25
To exactly quantify the distribution of the acidic
degradation products and monitor their subtle
variation during degradation, a simple, yet highly
sensitive, specific and reproducible analytical
method needs to be developed. High-pressure
liquid chromatography (HPLC) has been used to
determine polymer degradation products.26–28
However, these studies either could not achieve
simultaneous determination of both glycolic and
lactic acids or only identified and quantifiedmono-
mers, the final degradation products, while
neglecting the possible existence of the water-
soluble dimers and oligomers. Exact quantifica-
tion of dimers and oligomers cannot be achieved by
simply imposing the same standard curve of
monomer on their peak areas, considering poten-
tial differences of extinction coefficients for each
acid. To date, no efforts have been reported to
exactly quantify water-soluble oligomers due to
the lack of standards. Furthermore, existing
methods directly detect acids at 210 nm, a wave-
length very close to the cut-off range of many
commonly used mobile phases, which may
increase the baseline noise and reduce the sensi-
tivity and detectability.
We sought to overcome the aforementioned
drawbacks by simply converting acids to products
with the same chromophore, which can be easily
and accurately detected by HPLC at a detectable
wavelength. In this study, we separated and
exactly quantified the water-soluble polymer
degradation products inside thin PLGA films
during incubation by extracting the water-soluble
acids from the polymer, derivatizing them to form
stable bromophenacyl esters, and then quantify-
ing them by reversed-phase HPLC.
EXPERIMENTAL
Chemicals
Poly(D,L-lactide-co-glycolide) 50:50, 85/15 with
inherent viscosity (i.v.) of 0.63 and 0.66 dL/g in
hexafluoroisopropanol, and poly(D,L-lactide) with
inherent viscosity of 0.60 dL/g in chloroform
were purchased from Birmingham Polymers,
Inc. (Birmingham, AL). D,L-Lactide and glycolide
were generously provided by Purac Biochem
(Gorinchem, Netherlands). All other chemicals
were of analytical grade or HPLC grade and
purchased from commercial suppliers.
PLGA Film Preparation and erosion
The polymer film-coated electrode method, simi-
lar to that used previously by our group29 for
measuring microclimate pH inside thin PLGA
films, was used to prepare the PLGAs films for
analysis. Microclimate pH measurements in the
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same specimens and a theoretical model for its
prediction will be reported in a future paper.
Standard noncombination-type, pH-sensitive,
glass electrodes (Fisher Scientific, Pittsburgh,
PA) were coated with PLGA by immersing the
electrodes into PLGA in acetone (500 mg/mL)
followed by subsequent quenching in double-
distilled water at 48C for 1 h. Coated electrodes
were dried at room temperature for 1 h before
being placed in a vacuum oven for further drying
for 36 h at room temperature. A light microscope
with a scale bar was used to measure the coating
thicknesses of the polymer films, which were
200–250 mm.
To avoid buffer penetration into the micro-
climate of the polymer film from the edge of
the coating, paraffin was used to seal the surface
above the ion-sensitive glass bulb of the electrode
before the film coating (30 mg) was incubated in
phosphatebufferedsaline (pH7.4) containing5mL
of 0.02% w/v Tween1 80 (PBST) at 378C for 6
weeks. Incubation media were replaced weekly to
maintain buffer pH, and the incubation tubeswere
sealed by paraffin to avoid partial evaporation of
the fluid.
Extraction and Preparation of
Water-Soluble Acids
At predetermined time points, polymer films were
carefully cut, peeled off from the electrode bulb,
and freeze-dried before extraction. Each pre-
weighed film was dissolved in 1 mL of chloroform
before adding 5 mL of double-distilled water.
After mixing by mild vortexing, the biphasic
solution was left for 10min before being separated
by centrifugation at 48C. The upper water layer
was quickly removed and frozen with liquid
nitrogen. The extraction was repeated five times,
and finally the water phases were combined and
freeze-dried on a Freezone 6 freeze-drying system
(Labconco Corp., Kansas City, MO) at 133
103 mBar with a condenser temperature of
468C for 3–5 days. The dried extracts were then
dissolved in acetonitrile and further prepared for
titration or HPLC analysis as described below.
Acid Quantification by Potentiometric Titration
The dried water-soluble acid extracts just
described were reconstituted in 1 mL of degassed
ACN–H2O mixture (20:80, v/v) and then titrated
with 0.1 M tetrabutyl ammonium hydroxide
(TBAH) in the same solvent mixture. The electro-
motive force (EMF) was recorded as a function of
the titrant added with a Corning Semi-Micro
Combination glass pH-electrode (VWR Scientific,
West Chester, PA) attached to an Orion pH meter
(Fisher Scientific, Pittsburgh, PA).
Derivatization of Acids to Bromophenacyl Esters
Acid Derivatization
Dried water-soluble acid extracts were reconsti-
tuted in ACN, and a 2-fold mole excess of
triethylamine (TEA) and bromophenacyl bromide
(pBPB) solution in ACN were added. The solu-
tion was put in amber glass threaded vials for the
protection of the light-sensitive reagent and
sealed with rubber-lined closures. The reaction
was carried out at 508C for 3 h, and the re-
sulting solutions were stored at 48C before HPLC
analysis.
Preparation of Acid Standards
The standard solutions of bromophenacyl esters of
glycolic and lactic acids were prepared by adding
TEA and pBPB to acid solutions in ACN and
allowing the reaction to take place, as already
described. For the preparation of the linear dimer
of lactic acid (lactoyllactic acid), D,L-lactide was
added to water, and hydrolysis was carried out at
808C for 30 min. The resulting solution was
freeze-dried, and the residue consisted of viscous
oil, which was then dissolved in ACN and reacted
with TEA and pBPB. HPLC results indicated that
under the hydrolysis conditions used, lactide was
hydrolyzed almost completely (95%), producing
80% lactoyllactic and 20% lactic acid.
Characterization of Reaction Product by Nuclear
Magnetic Resonance (NMR) and Mass
Spectroscopic (MS) Analyses
The HPLC fraction that contained individual
bromophenacyl esters of glycolic acid was col-
lected and air-dried to remove organic solvent
before freeze-drying. The dried sample was
reconstituted in deuterated acetonitrile (CD3CN)
or ACN and centrifuged, and the supernatant was
removed for NMR and MS analysis, respectively.
Samples dissolved in CD3CNwere immediately
transferred to an NMR tube and sealed. The 1H
NMRspectrumwas acquired on aDRX500Bruker
spectrometer (Bruker Biospin Inc., Billerica, MA)
operating at 500 MHz. The following conditions
were used: pulse angle¼ 908, pulse width¼ 11 ms,
delay between two successive pulses¼ 1 s.
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Mass spectrometry of supernatant dissolved in
ACN was carried out on a Micromass Autospec
Ultima Magnetic sector mass spectrometer
(Micromass, Wythenshawe, UK). The ions were
generated by chemical ionization with ammonia.
HPLC Analysis
A Waters HPLC system (Waters, Milford, MA)
was used for chromatographic separation of
bromophenacyl derivatives of water-soluble poly-
mer degradation products. It consisted of a binary
HPLC pump, autosampler, and ultraviolet (UV)
absorbance detector. Waters Breeze1 chromato-
graphy software was used to acquire and process
data. A 5-mm Symmetry1 C18 column (25 cm
4.6 mm i.d.; Waters, Milford, MA) was used with
a filtered and deaerated ACN:H2O (70:30, v/v)
mobile phase with the linear gradient to 80:20 (v/v)
from 2–4min. Chromatography was performed at
a flow rate of 1.5 mL/min, and the eluent absor-
bance was detected at 254 nm and room tempera-
ture. After 12 min, 100% ACN was used to elute
for 8 min.
The analytes in the standardmixture and in the
various samples were identified by comparing the
retention time of the relevant peaks with those of
the corresponding standards injected separately.
No distinction could be made between D- and L-
lactic acids. Quantification was carried out by
integration of the peak areas using the external
standard chromatographic method.
Polymer Film Morphology
The inner side of film coating, which had been
adjacent to electrode surface, was freeze-dried
and coated with gold-palladium by using Denton
Vacuum Desk II Cold Sputter (Enton Acuum Inc.,
Cherry Hill, NJ). Surface morphology was exam-
ined by a Hitachi S-3200N variable-pressure
scanning electron microscope (SEM; Hitachi
Ltd., Tokyo, Japan).
RESULTS AND DISCUSSION
Derivatization of PLGA Water-Soluble Acids
Bromophenacyl bromide (pBPB) was utilized here
for the preparation of UV-sensitive derivatives of
PLGA water-soluble acids. The derivatization
reaction proceeds as shown in Figure 1. Anhy-
drous conditions were required to avoid further
hydrolysis of oligomers during the reaction and
to maintain solubility of reaction reagents. The
optimization of the reaction parameters (i.e.,
temperature, time, and reaction reagents concen-
tration) was achieved with the combination of
HPLC analysis (data not shown). The reaction
product was applied on a C18 column and detected
at 254 nm with an ACN:H2O mixture as eluent,
and the peak area was used as the parameter for
the reaction evaluation. The optimized conditions
were selected based on the ease of the procedure,
short reaction time, high purity, and high reaction
yield.
The effect of the concentration ofpBPBandTEA
was examined by varying each concentration
independently. Generally, excess pBPB was
required to obtain a significant yield, indicated
by the peak area of the analytes. The maximum
yieldwas obtainedwhen themole ratio ofpBPB-to-
acidwas2:1, and therewas no significant change
in yield with further relative increase in pBPB.
TEA was used in the reaction to enhance the
nucleophilic property of the carboxylate anion. It
was observed that, with the mole ratio of TEA-to-
acid of >1:1, variation of TEA concentration also
did not affect reaction yield. Therefore, a large
excess of the reagents apparently is not required or
deleterious. The degree of completeness of the
derivatization reaction was also evaluated with
respect to the effect of reaction time and tempera-
ture. The reaction was conducted at 508C and
followed over 24 h. Conversion was not complete
after 2 h, but reached a maximum by 3 h. Longer
reaction time was not necessary. Examination of
the effect of temperature also revealed that, as
expected, some increase in temperature was
required to reduce derivatization time.
The final standard conditions for the reaction
was chosen as follows: reaction temperature, 508C;
Figure 1. Scheme for esterification of water soluble
acid extracts with pBPB.
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reaction time, 3 h; and acid/pBPB/TEA mole
ratio, 1:2:2. The yields were 90 3 and 89 3%
(meanSD, n¼ 3) for glycolic acid and lactic acid
standards, respectively. The relative purity of
the derivative was determined by HPLC, which
showed the single dominant peak for monomer
standards. The reproducibility of the derivatiza-
tion was evaluated by conducting the reaction in
triplicate and then analyzing each by HPLC (two
subsequent injections of each reaction solution),
which gave a coefficient of variation (CV) of 6%
(n¼ 6).
Verification of Structure of Synthesized
Acid Derivatives
The chemical structure of the derivatization
bromophenacyl ester product was confirmed by
1H NMR and MS analyses. The peak of the
derivatized glycolic acid standard was collected
from HPLC and analyzed. The 1H NMR (CD3CN)
spectrum is shown in Figure 2 with the corre-
sponding peak assignments. Singlets at 2.15 and
4.24 ppm correspond to protons in hydroxyl and
methyl groups, respectively, from the glycolic
moiety of the derivative. The singlet at 5.40 ppm
and quadruple peak at 7.80 ppm were assigned
to protons in the acyl group and aromatic ring of
the bromophenacyl moiety of the derivative,
respectively.
The chemical ionization mass spectrometric
analysiswithammoniawasusedand the spectrum
was recorded, as shown in Figure 3. Themolecular
weight of the derivative was characterized by
[MNH4]
þ ions (m/z¼ 290, 292) and some intense
fragmentations, such as derived from the p-
bromophenacyl moiety (m/z¼ 183, 185) and
[CH2OHCOONH4]
þ group (m/z¼ 93). The isotope
pattern of the signals was due to the existence of
the bromine isotopes.
Based on these results, we confirmed that the
derivative is the bromophenacyl ester of glycolic
acid. Thus, the different peaks on HPLC chroma-
tograms were safely assigned to the esters of cor-
responding acid monomers and oligomers.
HPLC Separation and Determination
of Water-Soluble Acids
The HPLC baseline separation of a standard
mixture of derivatized glycolic, lactic, and lactoyl-
lactic acids is shown in Figure 4. The peaks were
assigned by matching each peak with the separ-
ate HPLC chromatograms of the individual acid
standards. A typical HPLC chromatogram of
water-soluble degradation products of PLGA
50:50 film following three weeks of incubation in
PBST buffer is shown in Figure 5. The well-
resolved lactic and lactoyllactic acid peaks in the
Figure 2. 1H-NMR (CD3CN) spectra of the ester
product of glycolic acid and pBPB collected from HPLC.
Figure 3. Mass spectrum of the reaction product of
glycolic acid and pBPB in the presence of ammonia.
Figure 4. HPLC chromatogram of the mixture of
reaction product of pBPB and three standards, (1)
glycolic acid, (2) lactic acid, and (3) lactoyllactic acid,
and (4) excess reagent pBPB.
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sample chromatogram displayed the exact same
result as in the separation of standard mixture,
which indicates the absence of a linear dimer peak
of glycolic acid that is expected between lactic
and lactoyllactic acid peaks. The possibility of an
overlap of lactic and glycolic acid dimer was ruled
out because the linear dimer of glycolic acid was
observed to be highly unstable in aqueous solu-
tion.28 It was observed that during the first
3 weeks of incubation, the main components of
water-soluble acids were glycolic, lactic, and lacto-
yllactic acids, and one unknown oligomer.
Identification of the unknown oligomer was
problematic, because we did not have the corre-
sponding standard to identify this oligomer and
the derivatized monomers and oligomers are not
easily ionized by liquid chromatography–mass
spectrometry (LC–MS) systems. Therefore, we
sought to speculate about the unknown oligomer
identity from the adjusted retention time of its
bromophenacyl ester. For a homologous series, the
adjusted retention time (t0R) has the following
linear relationship with the number of the repeat-
ing unit in their structures:30
log t0RðmÞ  log t0RðnÞ ¼ bðm nÞ ð1Þ
where m and n are the number of the repeating
unit of any two members in the homologous
series, and b is the slope. At the constant ratio of
ACN/H2O at 70:30 as mobile phase, t
0
R values for
lactic and lactoyllactic acids were measured as
0.98 and 1.35 min, respectively, which makes
the theoretical t0R for a tetramer of lactic acid
2.56 min. Because this theoretical value was
very close to the t0R value of the unknown oligomer
(2.50 min) and this oligomer peak was present in
PLA films not containing glycolic acid, it is
reasonable to speculate that this oligomer is the
tetramer of lactic acid.
In addition to the four dominant peaks just
described, therewere several tinypeaksappearing
in the chromatogram after 3 and 7 min. The latter
can be attributed to the esters of oligomers of
higher polymerization degree, but their relative
amount was small. However, after 4 weeks, more
oligomer peaks appeared and became more pro-
nounced with time. Some of these peaks could not
be baseline separated. A further improvement of
the resolution may be difficult under the current
HPLC column conditions. For those incompletely
separated oligomers, mean retention time was
used in the later polymer degradation behavior
analysis. Pure ACN was used to elute the column
after 12 min to flush out the possible longer chain
oligomers, but no additional peaks were found.
The retention time of the high excess derivati-
zation reagent pBPB was significantly different
from those esters of the primary degradation
products. The possibility of a peak overlap from
pBPBandapossible oligomer peakwas discounted
because no peak appeared at the pBPB retention
time when pBPB was not used in excess in the
reaction solution.
The calibration of peak areas against concen-
trations generated linear functions (r2¼ 0.999)
for both glycolic and lactic acid standards within
a range 0.25–1.5 mmol/mL. The same slopes were
observed as a result of existence of the same chro-
mophore, which verified the accuracy of quantifi-
cation of oligomers by a samplemonomer standard
curve. The detection limit was estimated to be
0.008 mmol/mL, corresponding to 4 104 mmol/
mg PLGA for the current analytical conditions.
Theprecision of themethod, evaluatedby repeated
injection of a standard solution with a concentra-
tion of 0.5 mmol/mL,was represented by aCVof the
retention times of <1.0%, and a CV of peak areas
of <2.8% (n¼ 6). The possible interference of the
coexisting acid species on individual acid quanti-
fication was tested by comparing chromatograms
of derivatized pure acid and acid standard mix-
ture, and no significant deviation was observed.
Water-Soluble Acids Inside PLGA 50:50
Films during Polymer Degradation
Total water-soluble acid content inside PLGA
50:50 films during polymer degradation was
obtained by repeated liquid–liquid extraction
using chloroform to dissolve the polymer and
water to recover the low molecular weight acids.
Figure 5. Typical HPLC chromatogram of water-
soluble PLGA 50:50 degradation products after conver-
sion to bromophenol esters after polymerfilm incubation
for 3 weeks in PBST at 378C. Key; (*) peak of unknown
oligomer believed to be a tetramer of lactic acid.
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The completion of the extraction was tested by
adding known amount of monomers in the organic
phase followed by repeated extraction and acid
recovery measurement by potentiometric titra-
tion. It was shown that 97 5 and 95 7%
(meanSD, n¼ 3) were recovered for glycolic
and lactic acids, respectively.
Total water-soluble acid content was quantified
separately both by the developed HPLC method
and potentiometric titration. TBAH, as a strongly
basic quaternary ammonium base, was used as a
titrant to avoid the possible alkali error of the glass
electrode.A small amount ofACN(20%)wasadded
to maintain the solubility of formed tetrabutyl
ammonium salts. Both titrant and samples were
prepared in the same solvent system (ACN/
H2O¼ 1:4), thus hydronium ion activity was
measured in the consistent system without the
disturbance of the added titrant. Possible inter-
ference of carbon dioxide was largely avoided by
degassing the solvent before titration. Electro-
motive force (EMF) was recorded as a function of
the quantity of titrant added. The end point corre-
sponds to the inflection point of the potentiometric
titration curve andwas obtained by taking thefirst
derivative. Typical titration and end-point deter-
mination curves for water-soluble acid quantifica-
tion are shown in Figure 6.
Kinetics of total water-soluble acid content
inside PLGA 50:50 films was quantified by titra-
tion and is shown in Figure 7A after normalization
by dry film weight. The acid content increased
dramatically after 3 weeks, which was due to the
continuous accumulation of acids from polymer
degradation and accelerated degradation rate
caused by those acids, which auto-catalyze polye-
ster hydrolysis.18 As seen in Figure 7B, total acid
content measurements from potentiometric titra-
tion were essentially identical to those data
obtained by the prederivatization HPLC method,
thus demonstrating the validity of the two analy-
tical procedures.
The relative composition of water-soluble acids
is shown in Figure 8. Glycolic, lactic, and lactoyl-
lactic acids, and the hypothesized lactic acid
Figure 6. Typical potentiometric titration curve (*)
and end-point determination (*) of total water-soluble
acids extracted from PLGA films.
Figure 7. Determination of total PLGA 50:50 water-
soluble acid content: (A) kinetics of total residual
water-soluble acids; (B) comparison of total residual
water-soluble acids quantified by potentiometric titra-
tion and by HPLC (n¼ 3, meanSE).
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tetramer were the major components. Lactoyllac-
tic acid content was relatively high during the first
2 weeks, which may be due to the existence of the
residual lactide after polymer synthesis and its
relatively high stability.Although the linear dimer
of glycolic acid was unstable and hydrolyzed to
glycolic acid quickly, the lactoyllactic acid can
remain intact for a much longer time.28 A rela-
tively low composition of glycolic acid was ob-
served, which is not surprising because glycolic
acid has been observed to be released out 3–
4 times faster than lactic acid.26,28 After 4 weeks
of incubation, all short-chain acids (monomers
and dimer) decreased, whereas more oligo-
mers appeared and their relative composition
increased. This increase may be caused by mobi-
lization of polymer chains, which facilitates ran-
dom scission relative to end scission.31
Polymer Composition Effect on Water-Soluble
Acid Production and Polymer Degradation
The developed acid derivatization followed by
HPLC analysis can be used to analyze the de-
gradation behavior of PLGAs other than PLGA
50:50. The HPLC chromatograms of acids recov-
ered from PLGA 50:50 and 85:15, and PLA films
after 1 week of incubation are compared in
Figure 9. Water-soluble acids were mainly com-
posed of lactic and lactoyllactic acids and the
hypothesized lactic acid tetramer for all of those
polymers including PLA. As expected, compared
with PLGA 50:50, no substantial peak of glycolic
acid ester was observed in PLGA 85:15 films
because of the lower glycolic acid content in poly-
mer material. As lactide content in the polymer
was increased from 50 to 100%, a reduction in
peak areas of corresponding acids was observed,
which was due to the slower degradation rate of
the lactide-rich copolymer and homopolymer.27,32
Significant mass loss was observed after
4 weeks of incubation of PLGA 50:50 films (data
not shown), corresponding to the well-known
induction time of bulk-degradable PLGA,33 and
PLGA 50:50 films became highly viscoelastic at
6 weeks. By contrast, with the relatively slower
degradation rate, PLGA 85:15 and PLA films
withstood no significant mass loss or visible
changes in physical state during 6 weeks of
incubation. The morphology of the inner side of
the polymer films (adjacent to the electrode sur-
face) after 4 weeks of incubation is compared in
Figure 10. Bulk porosity was the most ex-
tensive for PLGA 50:50 films with highest pore
volume fractions and pore diameter. Smaller pores
were scattered throughout PLGA 85:15 films,
whereas PLA films were relatively nonporous.
Figure 8. Relative molar composition of a variety of
water-soluble acids inside the polymer matrix during
PLGA50:50filmdegradation.Key: (*) glycolic acid; (&)
lactic acid; (~) lactoyllactic acid; (}) oligomer 1; (*)
oligomer 2; (!) oligomer 3; (&) oligomer 4 (n¼ 3,
meanSE).
Figure 9. HPLC chromatograms of polymer degrada-
tion products after conversion to bromophenol esters of
(A) PLGA 50:50 (i.v.¼ 0.63 dL/g), (B) PLGA 85:15
(i.v.¼ 0.66 dL/g), and (C) PLA (i.v.¼ 0.60 dL/g) after
polymer films were incubated for 1 week in PBST at
378C.
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In closing, a prederivatization HPLC method
was developed to accurately determine the water-
soluble acid distribution indegradingPLGAs.This
technique may have numerous applications in
PLGAcharacterization, including disclosure of the
underlying mechanism of polymer microclimate
pH development.
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